# Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction

Study · id `cardio:ct-nct02594488` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02594488](<https://clinicaltrials.gov/study/NCT02594488>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02594488

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.

## Technical summary

Registry record NCT02594488. Randomized; no masking; primary purpose diagnostic. Start 2016-05-06 (actual); primary completion 2021-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 400 participants (enrolled count; ClinicalTrials.gov record NCT02594488, source copy `cardio:ctgov-nct02594488-2021-06-23`, retrieved 2026-10-26)
- Started: 2016-05-06 (actual) (ClinicalTrials.gov record NCT02594488, source copy `cardio:ctgov-nct02594488-2021-06-23`, retrieved 2026-10-26)
- Primary completion: 2021-02 (actual) (ClinicalTrials.gov record NCT02594488, source copy `cardio:ctgov-nct02594488-2021-06-23`, retrieved 2026-10-26)
- Completion: 2021-02 (actual) (ClinicalTrials.gov record NCT02594488, source copy `cardio:ctgov-nct02594488-2021-06-23`, retrieved 2026-10-26)
- Countries: Austria; Germany (ClinicalTrials.gov record NCT02594488, source copy `cardio:ctgov-nct02594488-2021-06-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02594488-2021-06-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction
- Acronym: SMART-MI
- Condition: Myocardial Infarction
- Condition: Autonomic Nervous System Diseases
- Intervention (Device): Medtronic Reveal LINQ implantable cardiac monitor
- Lead sponsor: LMU Klinikum
- Lead sponsor class: OTHER
- Collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator class: OTHER
- Collaborator: Medtronic Cardiac Rhythm and Heart Failure
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: LMU Klinikum (`cardio:org-lmu-klinikum`)
- Registry lists this organization as a collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (`cardio:org-deutsches-zentrum-fur-herz-kreislauf-forschung-dzhk`)
- Registry lists this organization as a collaborator: Medtronic Cardiac Rhythm and Heart Failure (`cardio:org-medtronic-cardiac-rhythm-and-heart-failure`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial (`cardio:pubmed-35090674`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 71568f56434fe6f5cecdd16a4c0e46ea63e86459b7f842c6029c8575ce2a1786
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
